To better investigate the correlations between imaging response and HCC biomarkers kinetics, we developed a model of tumor dynamics with a set of ordinary differential equations that was used to fit measured AFP and PIVKA-II serum levels, according to basic biological assumptions and known mechanisms of action of sorafenib and regorafenib. Here, AFP is linked to hepatocellular carcinoma.